{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:51:06Z","timestamp":1780429866136,"version":"3.54.1"},"reference-count":70,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.3892\/etm.2014.1494","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T14:11:21Z","timestamp":1390313481000},"page":"763-767","source":"Crossref","is-referenced-by-count":18,"title":["Clinical application of expectorant therapy in chronic inflammatory airway diseases (Review)"],"prefix":"10.3892","volume":"7","author":[{"given":"TING","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANGDONG","family":"ZHOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"key20180108124919_b1-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-6749(90)90147-V","article-title":"Pathogenesis of airway mucus hypersecretion","volume":"85","author":"Lundgren","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"key20180108124919_b2-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/0470868678.ch5","article-title":"Mucus hypersecretion in chronic obstructive pulmonary disease","volume":"234","author":"Rogers","year":"2001","journal-title":"Novartis Found Symp"},{"key":"key20180108124919_b3-etm-07-04-0763","first-page":"437","article-title":"Chronic obstructive pulmonary disease airway mucin molecular phenotypic studies","volume":"25","author":"Zhou","year":"2002","journal-title":"Chin J Tuberc Respir Dis"},{"key":"key20180108124919_b4-etm-07-04-0763","first-page":"3277","article-title":"Epidemiological studies in mucus hypersecretion","volume":"248","author":"Vestbo","year":"2002","journal-title":"Novartis Found Symp"},{"key":"key20180108124919_b5-etm-07-04-0763","first-page":"1134","article-title":"Physiology of airway mucus secretion and pathophysiology of hypersecretion","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir Care"},{"key":"key20180108124919_b6-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.physiol.70.113006.100638","article-title":"Regulated airway goblet cell mucin secretion","volume":"70","author":"Davis","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"key20180108124919_b7-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"key20180108124919_b8-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09059180.00002710","article-title":"Revisited role for mucus hypersecretion in the pathogenesis of COPD","volume":"19","author":"Cerveri","year":"2010","journal-title":"Eur Respir Rev"},{"key":"key20180108124919_b9-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1183\/09059180.00004410","article-title":"Mucus hypersecretion in COPD: should we only rely on symptoms?","volume":"19","author":"Burgel","year":"2010","journal-title":"Eur Respir Rev"},{"key":"key20180108124919_b10-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/jamp.2009.0802","article-title":"New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways","volume":"23","author":"Lai","year":"2010","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"key20180108124919_b11-etm-07-04-0763","first-page":"1176","article-title":"Mucoactive agents for airway mucus hypersecretory diseases","volume":"52","author":"Rogers","year":"2007","journal-title":"Respir Care"},{"key":"key20180108124919_b12-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/15412550500218148","article-title":"The role of airway secretions in COPD - clinical applications","volume":"2","author":"Henke","year":"2005","journal-title":"COPD"},{"key":"key20180108124919_b13-etm-07-04-0763","first-page":"254277","article-title":"Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases","volume":"248","author":"Disse","year":"2002","journal-title":"Novartis Found Symp"},{"key":"key20180108124919_b14-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pharmthera.2008.11.001","article-title":"Airway mucus: the good, the bad, the sticky","volume":"121","author":"Evans","year":"2009","journal-title":"Pharmacol Ther"},{"key":"key20180108124919_b15-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.08-0412","article-title":"Mucins, mucus, and sputum","volume":"135","author":"Voynow","year":"2009","journal-title":"Chest"},{"key":"key20180108124919_b16-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mcp.0000198064.27586.37","article-title":"Mucus and MUC in asthma","volume":"12","author":"Morcillo","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"key20180108124919_b17-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/rccm.200603-381OC","article-title":"Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm","volume":"175","author":"de Marco","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108124919_b18-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/thx.2005.046227","article-title":"Convergence of the epidemiology and pathology of COPD","volume":"61","author":"Vestbo","year":"2006","journal-title":"Thorax"},{"key":"key20180108124919_b19-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1074\/jbc.M109958200","article-title":"Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and\/or sulfated Lewis \u00d7 epitopes in the human bronchial mucosa","volume":"277","author":"Delmotte","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180108124919_b20-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.200612-1772OC","article-title":"Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology","volume":"176","author":"Hogg","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108124919_b21-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/07853890600585795","article-title":"Treatment of airway mucus hypersecretion","volume":"38","author":"Rogers","year":"2006","journal-title":"Ann Med"},{"key":"key20180108124919_b22-etm-07-04-0763","first-page":"237277","article-title":"Current and future therapies for airway mucus hypersecretion","volume":"248","author":"Barnes","year":"2002","journal-title":"Novartis Found Symp"},{"key":"key20180108124919_b23-etm-07-04-0763","first-page":"23","article-title":"The market analysis of Ambroxol in China","volume":"22","author":"Lun","year":"2006","journal-title":"Chinese Pharmaceutical Information"},{"key":"key20180108124919_b24-etm-07-04-0763","first-page":"557","article-title":"Antiinflammatory properties of ambroxol","volume":"13","author":"Beeh","year":"2008","journal-title":"Eur J Med Res"},{"key":"key20180108124919_b25-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20180108124919_b26-etm-07-04-0763","first-page":"99","article-title":"The role for N-acetylcysteine in the management of COPD","volume":"1","author":"Dekhuijzen","year":"2006","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"key20180108124919_b27-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pupt.2005.12.007","article-title":"Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review","volume":"20","author":"Sadowska","year":"2007","journal-title":"Pulm Pharmacol Ther"},{"key":"key20180108124919_b28-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1378\/chest.09-0421","article-title":"Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study","volume":"136","author":"Stav","year":"2009","journal-title":"Chest"},{"key":"key20180108124919_b29-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000029447","article-title":"N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD","volume":"66","author":"Pela","year":"1999","journal-title":"Respiration"},{"key":"key20180108124919_b30-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.03.00063402","article-title":"N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease","volume":"21","author":"Gerrits","year":"2003","journal-title":"Eur Respir J"},{"key":"key20180108124919_b31-etm-07-04-0763","first-page":"265","article-title":"N-acetylcysteine: multiple clinical applications","volume":"80","author":"Millea","year":"2009","journal-title":"Am Fam Physician"},{"key":"key20180108124919_b32-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2147\/COPD.S3735","article-title":"The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease","volume":"3","author":"Hooper","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"key20180108124919_b33-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"key":"key20180108124919_b34-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1532-5415.2005.00592_9.x","article-title":"Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease","volume":"54","author":"Yasuda","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"key20180108124919_b35-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1111\/j.1532-5415.2007.01373.x","article-title":"Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease","volume":"55","author":"Tatsumi","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"key20180108124919_b36-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/187152808784165153","article-title":"Emerging mucus regulating drugs in inflammatory and allergic lung disease","volume":"7","author":"Hauber","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"key20180108124919_b37-etm-07-04-0763","first-page":"183","article-title":"Advances in studies on Platycodon grandiflorum","volume":"32","author":"Li","year":"2007","journal-title":"China Journal of Chinese Materia Medica"},{"key":"key20180108124919_b38-etm-07-04-0763","first-page":"281","article-title":"Studies on expectorant compounds in volatile oil from root and rhizome of Aster tataricus","volume":"33","author":"Bin","year":"2008","journal-title":"China Journal of Chinese Materia Medica"},{"key":"key20180108124919_b39-etm-07-04-0763","first-page":"207","article-title":"Antitussive, expectorant and antibacterial actions of Zhebei Zhike granules","volume":"17","author":"Haiqing","year":"2011","journal-title":"Chinese Journal of Experimental Traditional Medical Formulae"},{"key":"key20180108124919_b40-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.4049\/jimmunol.172.5.2903","article-title":"A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma","volume":"172","author":"McKay","year":"2004","journal-title":"J Immunol"},{"key":"key20180108124919_b41-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","article-title":"Statins as anti-inflammatory agents","volume":"23","author":"Weitz-Schmidt","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"key20180108124919_b42-etm-07-04-0763","first-page":"213","article-title":"Effect of simvastatin on airway mucus hypersecretion in rats and its molecular mechanism","volume":"30","author":"Wang","year":"2008","journal-title":"Di 3 Jun Yi Da Xue Xue Bao"},{"key":"key20180108124919_b43-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1183\/09031936.00106406","article-title":"Statin use is associated with reduced mortality in COPD","volume":"29","author":"S\u00f8yseth","year":"2007","journal-title":"Eur Respir J"},{"key":"key20180108124919_b44-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key20180108124919_b45-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.lungcan.2004.11.027","article-title":"Novel effects of gefitinib on mucin production in bronchioloalveolar carcinoma; two case reports","volume":"49","author":"Kitazaki","year":"2005","journal-title":"Lung Cancer"},{"key":"key20180108124919_b46-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2005.05.005","article-title":"Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells","volume":"50","author":"Kitazaki","year":"2005","journal-title":"Lung Cancer"},{"key":"key20180108124919_b47-etm-07-04-0763","first-page":"231","article-title":"Effect of gefinitib on airway mucus hypertension induced by acrolein in rats","volume":"39","author":"Guan","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"key20180108124919_b48-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.rmed.2003.12.012","article-title":"PDE4 inhibitors in COPD - a more selective approach to treatment","volume":"98","author":"Vignola","year":"2004","journal-title":"Respir Med"},{"key":"key20180108124919_b49-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/13543784.16.1.109","article-title":"Phosphodiesterase-4 inhibitors as a novel approach for the treatment of respiratory disease: cilomilast","volume":"16","author":"Kroegel","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"key20180108124919_b50-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/clpt.2011.266","article-title":"PDE4: a novel target in the treatment of chronic obstructive pulmonary disease","volume":"91","author":"Michalski","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"key20180108124919_b51-etm-07-04-0763","first-page":"143","article-title":"The effect of long-term treatment with erdosteine on chronic obstructive pulmonary disease: the EQUALIFE Study","volume":"30","author":"Moretti","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"key20180108124919_b52-etm-07-04-0763","first-page":"612","article-title":"Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study)","volume":"33","author":"Marchioni","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key20180108124919_b53-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.00018508","article-title":"Effect of fudosteine on mucin production","volume":"32","author":"Rhee","year":"2008","journal-title":"Eur Respir J"},{"key":"key20180108124919_b54-etm-07-04-0763","first-page":"369","article-title":"A randomized controlled trial of expectorant in patients with respiratory tract infection","volume":"25","author":"Xin","year":"2006","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"key":"key20180108124919_b55-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.intimp.2012.07.008","article-title":"The effect of quercetin on human neutrophil elastase-induced mucin5AC expression in human airway epithelial cells","volume":"14","author":"Li","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"key20180108124919_b56-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10753-011-9314-8","article-title":"Theaflavins extracted from black tea inhibit airway mucous hypersecretion induced by cigarette smoke in rats","volume":"35","author":"Wu","year":"2012","journal-title":"Inflammation"},{"key":"key20180108124919_b57-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/ptr.2817","article-title":"Kaempferol and quercetin, essential ingredients in Ginkgo biloba extract, inhibit interleukin-1beta-induced MUC5AC gene expression in human airway epithelial cells","volume":"23","author":"Kwon","year":"2009","journal-title":"Phytother Res"},{"key":"key20180108124919_b58-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0703822","article-title":"Effect of the long-acting tachykinin NK(1) receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets","volume":"132","author":"Khan","year":"2001","journal-title":"Br J Pharmacol"},{"key":"key20180108124919_b59-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.4049\/jimmunol.175.6.4009","article-title":"Neutrophil elastase induces MUC5AC mucin production in human airway epithelial cells via a cascade involving protein kinase C, reactive oxygen species, and TNF-alpha-converting enzyme","volume":"15","author":"Shao","year":"2005","journal-title":"J Immunol"},{"key":"key20180108124919_b60-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/jam.2004.17.289","article-title":"Potential role of inhibitors of neutrophil elastase in treating diseases of the airway","volume":"17","author":"Chughtai","year":"2004","journal-title":"J Aerosol Med"},{"key":"key20180108124919_b61-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijbiomac.2012.04.023","article-title":"Direct interaction of ONO-5046 with human neutrophil elastase through 1H NMR and molecular docking","volume":"51","author":"Feng","year":"2012","journal-title":"Int J Biol Macromol"},{"key":"key20180108124919_b62-etm-07-04-0763","first-page":"1042","article-title":"Sivelestat sodium hydrate was effective for ARDS in a patient suffering from chronic rheumatoid arthritis with acute exacerbation after failing to respond to high dose steroid pulse therapy","volume":"53","author":"Tomiyama","year":"2004","journal-title":"Masui"},{"key":"key20180108124919_b63-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2222.2003.01612.x","article-title":"Extended freeze-dried Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin induces the release of interleukin-12 but not tumour necrosis factor-\u03b1 by alveolar macrophages, both in vitro and in vivo","volume":"33","author":"Hubeau","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"key20180108124919_b64-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.2105079","article-title":"Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model","volume":"166","author":"Cheng","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key20180108124919_b65-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1398-9995.2009.02156.x","article-title":"Inhaled vs subcutaneous effects of a dual IL-4\/IL-13 antagonist in a monkey model of asthma","volume":"65","author":"Tomkinson","year":"2010","journal-title":"Allergy"},{"key":"key20180108124919_b66-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/WOX.0b013e3181e5ec5a","article-title":"Update on biological therapeutics for asthma","volume":"3","author":"Cook","year":"2010","journal-title":"World Allergy Organ J"},{"key":"key20180108124919_b67-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1152\/jappl.1999.87.6.2191","article-title":"Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep","volume":"87","author":"Sabater","year":"1999","journal-title":"J Appl Physiol (1985)"},{"key":"key20180108124919_b68-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1124\/jpet.102.035485","article-title":"Pharmacology of INS37217 [P(1)-(uridine 5\u2032)-P(4)- (2\u2032-deoxycytidine 5\u2032)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis","volume":"302","author":"Yerxa","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"5 Suppl","key":"key20180108124919_b69-etm-07-04-0763","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1378\/chest.121.5_suppl.201S","article-title":"P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance","volume":"121","author":"Kellerman","year":"2002","journal-title":"Chest"},{"key":"key20180108124919_b70-etm-07-04-0763","first-page":"CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"8","author":"Poole","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2014.1494\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:16:06Z","timestamp":1515449766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2014.1494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,1,21]]},"published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.3892\/etm.2014.1494"],"URL":"https:\/\/doi.org\/10.3892\/etm.2014.1494","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}